Compare OFLX & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OFLX | ACHV |
|---|---|---|
| Founded | 1975 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 294.7M | 239.0M |
| IPO Year | 2005 | N/A |
| Metric | OFLX | ACHV |
|---|---|---|
| Price | $30.22 | $5.19 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $15.50 |
| AVG Volume (30 Days) | 49.3K | ★ 577.5K |
| Earning Date | 10-29-2025 | 11-06-2025 |
| Dividend Yield | ★ 4.49% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.59 | N/A |
| Revenue | ★ $100,054,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $18.98 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $25.58 | $1.84 |
| 52 Week High | $43.18 | $5.78 |
| Indicator | OFLX | ACHV |
|---|---|---|
| Relative Strength Index (RSI) | 56.71 | 62.66 |
| Support Level | $29.00 | $4.30 |
| Resistance Level | $31.00 | $5.28 |
| Average True Range (ATR) | 1.36 | 0.26 |
| MACD | 0.06 | 0.07 |
| Stochastic Oscillator | 62.69 | 88.79 |
Omega Flex Inc is a manufacturer of flexible metal hoses, which is used in a variety of ways to carry gases and liquids within their particular applications. Omega sells its products under the TracPipe, CounterStrike, DoubleTrac, DEF-Trac and MediTrac brands. It serves various markets which include construction, manufacturing, transportation, petrochemical, pharmaceutical, and other industries. Geographically Omega Flex, Inc operates in the United States. The company derives revenues from the manufacture and sale of flexible metal hose and accessories.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.